Cardiorenal Effects of Recombinant Human Natriuretic Peptides

Journal of the American College of Cardiology

Volumn 55, Issue 17, 2010, Pages 1852-1853

  Voors, Adriaan A ^a   van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

atrial natriuretic factor; cardiopulmonary bypass; coronary artery bypass grafting; left ventricular dysfunction; natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR A; NESIRITIDE; PLACEBO;

ACUTE HEART FAILURE; CARDIOVASCULAR DISEASE; CORONARY ARTERY BYPASS SURGERY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; EDITORIAL; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART FUNCTION; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

HEART; HEART FAILURE; HUMANS; KIDNEY; NATRIURETIC PEPTIDES; RECOMBINANT PROTEINS;

EID: 77950896926     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.10.076     Document Type: Editorial

References (12)

1. Ruilope L.M., van Veldhuisen D.J., Ritz E., and Luscher T.F. Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol 38 (2001) 1782-1787
2. Sackner-Bernstein J.D., Skopicki H.A., and Aaronson K.D. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111 (2005) 1487-1491
3. Yancy C.W., Krum H., Massie B.M., et al., FUSION II Investigators. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial. Circ Heart Fail 1 (2008) 9-16
4. Loef B.G., Epema A.H., Smilde T.D., et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 16 (2005) 195-200
5. van de Wal R.M., van Brussel B.L., Voors A.A., et al. Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery. J Thorac Cardiovasc Surg 129 (2005) 330-335
6. Kristeller J.L., Papps H., and Stahl R.F. Risk of worsening renal function with nesiritide following cardiac surgery. Am J Health Syst Pharm 63 (2006) 2351-2353
7. Mentzer Jr. R.M., Oz M.C., Sladen R.N., et al., NAPA Investigators. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA trial. J Am Coll Cardiol 49 (2007) 716-726
8. Sezai A., Hata M., Niino T., et al. Continuous low-dose infusion of human atrial natriuretic peptide in patients with left ventricular dysfunction undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose Human ANP Infusion Therapy during cardiac surgery) for left ventricular dysfunction. J Am Coll Cardiol 55 (2010) 1844-1851
9. Jensen K.T., Carstens J., and Pedersen E.B. Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol 274 (1998) F63-F72
10. Damman K., Navis G., Smilde T.D., et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9 (2007) 872-878
11. Damman K., van Deursen V.M., Navis G., Voors A.A., van Veldhuisen D.J., and Hillege H.L. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53 (2009) 582-588
12. Hernandez A.F., O'Connor C.M., Starling R.C., et al. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure trial (ASCEND-HF). Am Heart J 157 (2009) 271-277